Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.
Sign Up to like & getrecommendations! Published in 2018 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2018.07.016
Abstract: OBJECTIVE To examine incidences and risk factors for metachronous vulvar, vaginal, and anal malignancies after a cervical cancer diagnosis. METHODS This is a retrospective study examining data from the Surveillance, Epidemiology, and End Result Program… read more here.
Keywords: vaginal anal; diagnosis; cervical cancer; risk factors ... See more keywords
Assessing symptomatic vulvar, vaginal, and lower urinary tract atrophy
Sign Up to like & getrecommendations! Published in 2019 at "Climacteric"
DOI: 10.1080/13697137.2019.1600499
Abstract: ABSTRACT The objective of this review is to provide an overview of existing and evolving methods of assessing symptomatic vulvar, vaginal, and lower urinary tract atrophy A systematic literature search was carried out on MEDLINE… read more here.
Keywords: urinary tract; tract atrophy; lower urinary; vaginal lower ... See more keywords
Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.14486
Abstract: Immune checkpoint inhibitors might be therapeutic options for unresectable or metastatic melanomas of the vulva and vagina but data available in the literature in these melanomas are very limited 1 2 3 4. The aim… read more here.
Keywords: inhibitors valuable; melanomas; checkpoint inhibitors; valuable option ... See more keywords
Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use
Sign Up to like & getrecommendations! Published in 2020 at "Patient preference and adherence"
DOI: 10.2147/ppa.s203614
Abstract: Abstract Endocrinological changes that occur with menopause lead to a chronic and progressive condition named vulvar and vaginal atrophy (VVA). This disease is characterized by symptoms such as dryness, dyspareunia, itching, burning, and dysuria. According… read more here.
Keywords: patient; ospemifene management; vaginal atrophy; vulvar vaginal ... See more keywords